- Home
- INAB vs SWVL Comparison
INAB vs SWVL Comparison
Compare INAB & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INAB | SWVL |
|---|---|---|
| Founded | 2016 | 2017 |
| Country | United States | United Arab Emirates |
| Employees | N/A | 284 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2M | 15.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | INAB | SWVL |
|---|---|---|
| Price | $1.51 | $1.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 58.0K | 25.3K |
| Earning Date | 05-11-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $1.31 |
| 52 Week High | $4.20 | $4.99 |
Technical Indicators
Market Signals| Indicator | INAB | SWVL |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 70.30 |
| Support Level | $1.35 | $1.33 |
| Resistance Level | $2.11 | $2.80 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 65.17 | 87.12 |
Price Performance
Historical ComparisonAbout INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.